Delivery Order SPE2DB25D7067-SPE2DB25FSVCN
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for MOVIPREP powder packets valued at $4,463.71 under a firm fixed-price contract. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is part...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $1,233.66 for MOVIPREP powder packets. Awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, this non-set-aside contract represents a small-value procurement from DLA's broader medical supply operations. The delivery order is performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of MOVIPREP powder packets, a bowel preparation medication, with a ceiling value of $1,233.66. This firm fixed-price contract, executed without a set-aside designation, represents a competitively awarded delivery order under the company's existing pharmaceutical supply agreement with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (Contract No. SPE2DX15D1021|SPE2DX24FHQUK) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,956,715 units of MOVIPREP Powder Packets. The delivery order has a ceiling value of $1,068.90 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of MOVIPREP Powder Packets. The $1,947.30 award does not have a set-aside designation and is part of an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This single...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,274.59, is for the delivery of MOVIPREP POWDER PACKETS, a medical supply item, with a period of performance through January 29, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $15,620.25 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA to provide a range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,153.95 order is for the supply of MOVIPREP powder packets, a specialty pharmaceutical product, with a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of MOVIPREP POWDER PACKETS, a pharmaceutical product, with a potential value of $3,467.31 and a completion date of March 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563589755 MOVIPREP POWDER PACKETS. The contract has a potential value of $1,001.76 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and the parent company Cencora, Inc. is the doing business as entity. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVCNDelivery Order
The Defense Logistics Agency awarded a $3,414.82 delivery order to AmerisourceBergen Drug Corp for MOVIPREP Powder Packets under a firm fixed price contract. The award, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, represents a non-competitive delivery order issued without set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical supply chain, particularly serving the Defense Health Agency and military healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. MOVIPREP, a bowel preparation solution commonly used in medical procedures, falls within the specialized pharmaceutical products that AmerisourceBergen regularly supplies to federal healthcare customers through its DLA prime vendor contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/27/25 |